Related references
Note: Only part of the references are listed.AGEs accumulation is related to muscle degeneration and vascular calcification in peritoneal dialysis patients
Lais de Faria Fonseca et al.
JORNAL BRASILEIRO DE NEFROLOGIA (2021)
Advanced glycation end products are associated with sarcopenia in older women: aging marker dynamics
Yawara Eguchi et al.
JOURNAL OF WOMEN & AGING (2021)
Circulating Irisin and esRAGE as Early Biomarkers of Decline of Metabolic Health
Elena Dozio et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Loss of high-temperature requirement protein A2 protease activity induces mitonuclear imbalance via differential regulation of mitochondrial biogenesis in sarcopenia
Zhou Haohan et al.
IUBMB LIFE (2020)
Mitochondrial biogenesis: An update
Lucia-Doina Popov
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia
Sara Chiappalupi et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell death
Takanobu Takata et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
Junko Yabuuchi et al.
SCIENTIFIC REPORTS (2020)
Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: A review
Philipp Jud et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Soluble Receptor for Advanced Glycation End Products: A Protective Molecule against Intramyocardial Lipid Accumulation in Obese Zucker Rats?
Elena Dozio et al.
MEDIATORS OF INFLAMMATION (2019)
Association of accumulated advanced glycation end-products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
Hiroyasu Mori et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice
Hannah M. Davis et al.
BONE (2019)
Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions
Hiroshi Watanabe et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2019)
Relationship among urinary advanced glycation-end products, skeletal muscle mass and physical performance in community-dwelling older adults
Chuan-Wei Yang et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2019)
Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases
Nurbubu T. Moldogazieva et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Advanced Glycation End-Products Suppress Mitochondrial Function and Proliferative Capacity of Achilles Tendon-Derived Fibroblasts
Shivam H. Patel et al.
SCIENTIFIC REPORTS (2019)
Methylglyoxal as a prognostic factor in patients with chronic kidney disease
Yuta Tezuka et al.
NEPHROLOGY (2019)
Sarcopenia and cardiovascular risk indices in patients with chronic kidney disease on conservative and replacement therapy
Silvia Lai et al.
NUTRITION (2019)
Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities
Eugenia Migliavacca et al.
NATURE COMMUNICATIONS (2019)
Skeletal muscle ex vivo mitochondrial respiration parallels decline in vivo oxidative capacity, cardiorespiratory fitness, and muscle strength: The Baltimore Longitudinal Study of Aging
Marta Gonzalez-Freire et al.
AGING CELL (2018)
Overexpression of PGC-1α in aging muscle enhances a subset of young-like molecular patterns
Sofia Garcia et al.
AGING CELL (2018)
Redox Systems, Antioxidants and Sarcopenia
Bertrand Fougere et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2018)
The association of low muscle mass with soluble receptor for advanced glycation end products (sRAGE): The Korean Sarcopenic Obesity Study (KSOS)
Tae Nyun Kim et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)
Non-invasive testing for sarcopenia predicts future cardiovascular events in patients with chronic kidney disease
Shinsuke Hanatani et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Advanced glycation end products in the pathogenesis of chronic kidney disease
Naila Rabbani et al.
KIDNEY INTERNATIONAL (2018)
RAGE-dependent mitochondria pathway: a novel target of silibinin against apoptosis of osteoblastic cells induced by advanced glycation end products
Y. X. Mao et al.
CELL DEATH & DISEASE (2018)
Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression
Danilo C. Pinto-Junior et al.
SCIENTIFIC REPORTS (2018)
Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant
Jesus Calvino et al.
PLOS ONE (2018)
AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease
Kailash Prasad et al.
INTERNATIONAL JOURNAL OF ANGIOLOGY (2018)
Relationship between soluble receptor for advanced glycation end products (sRAGE), body composition and fat distribution in healthy women
Elena Dozio et al.
EUROPEAN JOURNAL OF NUTRITION (2017)
Relationship between advanced glycation end-product accumulation and low skeletal muscle mass in Japanese men and women
Michitaka Kato et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2017)
Advanced glycation end products receptor RAGE controls myocardial dysfunction and oxidative stress in high-fat fed mice by sustaining mitochondrial dynamics and autophagy-lysosome pathway
Yichi Yu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
Salvatore Bongarzone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
Elena Dozio et al.
MEDIATORS OF INFLAMMATION (2017)
Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction
Yuki Enoki et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)
The Role of Oxidative Stress, Mitochondrial Function, and Autophagy in Diabetic Polyneuropathy
Sonia Sifuentes-Franco et al.
JOURNAL OF DIABETES RESEARCH (2017)
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy
Francesca Riuzzi et al.
SCIENTIFIC REPORTS (2017)
Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies
Antonio Nogueira et al.
IN VIVO (2017)
Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway
Chen-Yuan Chiu et al.
JOURNAL OF PATHOLOGY (2016)
CKD and Muscle Mitochondrial Energetics
Baback Roshanravan et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1 c dysregulation in mice
R. Mastrocola et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials
Rachel E. Clarke et al.
NUTRIENTS (2016)
Editorial: Mitochondria in Skeletal Muscle Health, Aging and Diseases
Gilles Gouspillou et al.
FRONTIERS IN PHYSIOLOGY (2016)
Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease
Jorge L. Gamboa et al.
PHYSIOLOGICAL REPORTS (2016)
Nε-(carboxymethyl) lysine-induced mitochondrial fission and mitophagy cause decreased insulin secretion from β-cells
Mei-Chen Lo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2015)
New roles for mitochondrial proteases in health, ageing and disease
Pedro M. Quiros et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality
Rassa A. Pereira et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Mitochondria: a new therapeutic target in chronic kidney disease
Simona Granata et al.
NUTRITION & METABOLISM (2015)
Accumulation of Advanced Glycation End-Products and Activation of the SCAP/SREBP Lipogenetic Pathway Occur in Diet-Induced Obese Mouse Skeletal Muscle
Raffaella Mastrocola et al.
PLOS ONE (2015)
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Kerstin Nowotny et al.
BIOMOLECULES (2015)
A nomogram to estimate the proportion of patients at hemoglobin A1c target <7% with noninsulin antidiabetic drugs in type 2 diabetes: a systematic review of 137 randomized controlled trials with 39 845 patients
Katherine Esposito et al.
ACTA DIABETOLOGICA (2014)
Serum Carboxymethyl-Lysine, Disability, and Frailty in Older Persons: The Cardiovascular Health Study
Heather E. Whitson et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2014)
Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression
Marita Liebisch et al.
KIDNEY INTERNATIONAL (2014)
Chronic kidney disease reduces muscle mitochondria and exercise endurance and its exacerbation by dietary protein through inactivation of pyruvate dehydrogenase
Masanori Tamaki et al.
KIDNEY INTERNATIONAL (2014)
Mechanisms of muscle wasting in chronic kidney disease
Xiaonan H. Wang et al.
NATURE REVIEWS NEPHROLOGY (2014)
Uraemic sarcopenia: aetiology and implications
Ibrahim H. Fahal
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death
Elizabeth Selvin et al.
DIABETES (2013)
Age-associated declines in mitochondrial biogenesis and protein quality control factors are minimized by exercise training
Erika Koltai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2012)
Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome
Naila Rabbani et al.
AMINO ACIDS (2012)
Reactive oxygen and nitrogen species as intracellular signals in skeletal muscle
Scott K. Powers et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Circulating Levels and Dietary Intake of the Advanced Glycation End-product Marker Carboxymethyl Lysine in Chronic Kidney Disease Patients on Conservative Predialysis Therapy: A Pilot Study
Marta Piroddi et al.
JOURNAL OF RENAL NUTRITION (2011)
Resistance Training Increases Muscle Mitochondrial Biogenesis in Patients with Chronic Kidney Disease
Vaidyanatha S. Balakrishnan et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study
Richard D. Semba et al.
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY (2010)
Aberrant Mitochondrial Homeostasis in the Skeletal Muscle of Sedentary Older Adults
Adeel Safdar et al.
PLOS ONE (2010)
Protection against Loss of Innate Defenses in Adulthood by Low Advanced Glycation End Products (AGE) Intake: Role of the Antiinflammatory AGE Receptor-1
Helen Vlassara et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Elevated Serum Advanced Glycation End Products and Poor Grip Strength in Older Community-Dwelling Women
Mansi Dalal et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2009)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42
Barry I. Hudson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Resistance Exercise Reverses Aging in Human Skeletal Muscle
Simon Melov et al.
PLOS ONE (2007)
Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes
Hiroyuki Unoki et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients
E. D. Siew et al.
KIDNEY INTERNATIONAL (2007)
Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE) - an introduction
Paul J. Thornalley
MOLECULAR NUTRITION & FOOD RESEARCH (2007)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Regulation of protein synthesis by insulin
CG Proud
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Increased muscle protein breakdown in chronic hemodialysis patients with type 2 diabetes mellitus
LB Pupim et al.
KIDNEY INTERNATIONAL (2005)
Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake
O Sandu et al.
DIABETES (2005)
Glycoxidation and inflammation in renal failure patients
M Peppa et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease
C Castaneda et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Effect of advanced glycation end-products on gene expression and synthesis of TNF-α and endothelial nitric oxide synthase by endothelial cells
G Rashid et al.
KIDNEY INTERNATIONAL (2004)
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
PS Brookes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through a protein kinase Cα-mediated mechanism
C Miele et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse
SM Hofmann et al.
DIABETES (2002)
Tumor necrosis factor-α suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes -: Nuclear factor-κB activation by TNF-α is obligatory
H Ruan et al.
DIABETES (2002)
Resistance training to counteract the catabolism of a low-protein diet in patients with chronic renal insufficiency - A randomized, controlled trial
C Castaneda et al.
ANNALS OF INTERNAL MEDICINE (2001)
The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy
T Shimoike et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Share Paper
